Aliri Bioanalysis

Navigating a robust regulatory environment, advancing your development program with speed, and accessing a breadth of technical expertise are all critical factors to the success of your program. Aliri provides a range of bioanalytical lab, spatial bioanalysis, and spatial biology solutions. As a result, we will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of seasoned scientists and technical experts.

FEATURED INSIGHTS

Oligonucleotides: Where We Are And Where We Would Like To Go 

This presentation provides an overview of oligonucleotide bioanalysis's current status and future directions. We will look into the advantages and disadvantages of various bioanalytical techniques.
Streamlining The Importing & Exporting Of Biological Samples

Create a seamless and predictable import and export process by working with experienced bioanalytical laboratory partners, understanding what paperwork samples require, and proactive planning.
Top 8 Benefits Of Mass Spectrometry Imaging Early In Drug Development

Here we explore the top 8 benefits of using mass spectrometry imaging in the oncology drug discovery and early development stages.
Top 5 Approaches To The Bioanalysis Of Oligonucleotides

Evaluate the strengths and limitations of each bioanalysis method carefully to choose the most effective strategy for your clinical study.
How A Drug's Molecule Type Affects Several Bioanalysis Parameters

Discover why bioanalytics are crucial to selecting promising drug candidates during development and to characterizing the pharmacokinetic and pharmacodynamic profile of the drug in early clinical trials.
7 Crucial Steps In Bioanalysis To Optimize Drug Development

On the journey toward creating effective therapies, the development of a rugged method for optimizing small molecule drug development strategies plays a pivotal role.
Understanding The Intricacies Of qMSI

Explore quantitative mass spectrometry imaging (QMSI) and leading spatial bioanalysis and biology services that offers one-on-one support throughout your drug development process.
The Future Of Small And Large Molecule Bioanalytics

Learn how innovative, emerging technologies are revolutionizing the field of bioanalytics and drug development.
Validating The Efficacy Of A Compound With Spatial Imaging

Discover how target and efficacy validation can translate into substantial savings and market advantages for sponsors as a result of shortened development and approval timelines.

CONTACT INFORMATION

Aliri Bioanalysis

4720 Forge Road, Suite 108

Colorado Springs, CO 80907

UNITED STATES

Phone: +1 (719) 593-1165

Fax: +1 (719) 593-1625

Request More Information

Visit Our Website

FEATURED SOLUTIONS

Validated Non-Proprietary Assay (NPA) List

Our extensive portfolio includes a wide range of validated, off-the-shelf assays designed to support various research applications, ensuring flexibility and efficiency in your projects.
Advancing Your Molecule With Speed And Agility

We offer a comprehensive suite of bioanalytical and spatial biology solutions designed to support the progression of your molecule from discovery through clinical development and product approval.
Toxicity Studies

Utilizing statistical analysis and a proprietary metabolomics database, see how we detect and identify molecular toxicity markers, providing critical safety insights into potential drug candidates.
LC/MS/MS Vs. LC/HRMS: Identifying And Quantifying Oligonucleotides

As OGNT-based therapeutics continue to gain traction in drug development, precise identification and quantification are essential for ensuring their efficacy and safety.
ATP Detection By Quantitative Mass Spec Imaging (QMSI)

By leveraging this approach, researchers can streamline workflows, reduce costs, and enhance the efficiency of their bioanalytical processes.
Bioanalytical Services For Animal Health

Our longstanding relationships with regulatory agencies ensure that we provide high-quality, compliant bioanalytical solutions that meet the rigorous standards necessary for drug approval.
Drug Discovery Bioanalytical Solutions: Quick Turnarounds For Lead Optimization

Leverage rapid, high-quality discovery bioanalysis to streamline your drug development process, optimize lead compounds, and meet evolving timelines with confidence.
Quantitative PCR (qPCR)

With decades of experience in molecular assay development for biomarker and PK/PD studies, our scientific team collaborates closely with sponsors to design tailored solutions.

WEBINARS AND VIDEOS

LC/MS Method For Measurement In Human Plasma

According to the researchers, this plasma-based measurement has the potential to serve as a critical pharmacodynamic biomarker, facilitating the assessment of novel therapeutic approaches.
LC/MS/MS Analysis Of Coproporphyrin 1, Coproporphyrin 3 In Human Plasma

This innovative approach holds promise for reducing the need for extensive clinical drug-drug interaction studies, potentially streamlining the drug development process.
Validation Of An LCMS Hybrid Assay With EVOSEP Cleanup

By leveraging this innovative combination, the assay achieves detection limits comparable to traditional methodologies while enhancing overall efficiency and reliability.
Antisense Oligonucleotide Extraction Optimization Reveals Differences

Our findings provide critical insights into refining ASO extraction protocols, which can enhance the accuracy of downstream analyses and support further research into ASO-based therapeutics.
Tissue Adenosine Distribution-Guided Gene Selection

Unlike conventional predictive biomarkers, which often focus on isolated molecular markers, this strategy integrates spatial metabolomics and genomics, providing a multidimensional perspective.
Webinar Teaser: LBA Vs. LC-MS

Why are so many sponsors shifting from Ligand-Binding Assays (LBA) to Liquid Chromatography-Mass Spectrometry (LC-MS) for large molecule protein analysis?
LBA Vs. LC-MS: Competing Technologies At A Development Crossroad

Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.
Elucidating The Role Of IL-18 In NSCLC Integrated Analysis

Hear how imaging mass cytometry, CyTOF, and single-cell sequencing unlock the secrets of the tumor microenvironment. Discover new insights into IL-18 and its impact on non-small cell lung cancer.
A Derivatization-Free LCMS Assay For 4β-hydroxycholesterol

Learn about a novel LCMS assay for 4β-hydroxycholesterol, a key biomarker for CYP3A activity. This derivatization-free method offers a faster and more efficient approach for clinical studies.
Development Of A Mitra Tip Extraction Assay Coupled With LC-MSMS

Watch this rundown of a novel method for quantifying L-Citrulline, L-Arginine, and L-Argininosuccinic acid using Mitra tip extraction coupled with LC-MS/MS for enhanced accuracy and reproducibility.

This website uses cookies to ensure you get the best experience on our website. Learn more